Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bina Desai

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancers|July 13, 2024
Dissecting the Spatially Restricted Effects of Microenvironment-Mediated Resistance on Targeted Therapy ResponsesTatiana Miti, Bina Desai, Daria Miroshnychenko, et al.
Nature Communications|September 16, 2025
Socioeconomic predictors of vulnerability to flood-induced displacementBenedikt Mester, Katja Frieler, Oliver Korup, et al.
Science (New York, N.Y.)|June 18, 2021
Addressing the human cost in a changing climateBina Desai, David N Bresch, Christelle Cazabat, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Evolutionary antifragile therapyJeffrey West, Bina Desai, Maximilian Strobl, et al.
Macromolecular Bioscience|May 10, 2017
Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer CellsTanmay Dichwalkar, Shraddha Patel, Samhita Bapat, et al.
Cancer Research|May 22, 2026
Evolutionary antifragile therapy is a treatment strategy to suppress drug resistance by exploiting dose response convexityJeffrey West, Bina Desai, Maximilian A R Strobl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung CancerRyoji Kato, Hitendra S Solanki, Hilal Ozakinci, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Trastuzumab Deruxtecan Combination Strongly Enhances Responses and Overcomes Sotorasib Resistance in <i>KRAS</i> <sup>G12C</sup> -Mutant NSCLCHilal Ozakinci, Bina Desai, Denise Kalos, et al.
Translational Lung Cancer Research|May 22, 2026
Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in <i>KRAS<sup>G12C</sup></i> -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumorsHilal Ozakinci, Bina Desai, Denise Kalos, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediatorsBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancers|July 13, 2024
Dissecting the Spatially Restricted Effects of Microenvironment-Mediated Resistance on Targeted Therapy ResponsesTatiana Miti, Bina Desai, Daria Miroshnychenko, et al.
Nature Communications|September 16, 2025
Socioeconomic predictors of vulnerability to flood-induced displacementBenedikt Mester, Katja Frieler, Oliver Korup, et al.
Science (New York, N.Y.)|June 18, 2021
Addressing the human cost in a changing climateBina Desai, David N Bresch, Christelle Cazabat, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Evolutionary antifragile therapyJeffrey West, Bina Desai, Maximilian Strobl, et al.
Macromolecular Bioscience|May 10, 2017
Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer CellsTanmay Dichwalkar, Shraddha Patel, Samhita Bapat, et al.
Cancer Research|May 22, 2026
Evolutionary antifragile therapy is a treatment strategy to suppress drug resistance by exploiting dose response convexityJeffrey West, Bina Desai, Maximilian A R Strobl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung CancerRyoji Kato, Hitendra S Solanki, Hilal Ozakinci, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Trastuzumab Deruxtecan Combination Strongly Enhances Responses and Overcomes Sotorasib Resistance in <i>KRAS</i> <sup>G12C</sup> -Mutant NSCLCHilal Ozakinci, Bina Desai, Denise Kalos, et al.
Translational Lung Cancer Research|May 22, 2026
Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in <i>KRAS<sup>G12C</sup></i> -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumorsHilal Ozakinci, Bina Desai, Denise Kalos, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediatorsBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Pageof 3